[go: up one dir, main page]

IL97656A - History of 1,3-dipropyl-8-aralkyl xanthine, the process for their preparation and medicinal preparations containing them - Google Patents

History of 1,3-dipropyl-8-aralkyl xanthine, the process for their preparation and medicinal preparations containing them

Info

Publication number
IL97656A
IL97656A IL9765691A IL9765691A IL97656A IL 97656 A IL97656 A IL 97656A IL 9765691 A IL9765691 A IL 9765691A IL 9765691 A IL9765691 A IL 9765691A IL 97656 A IL97656 A IL 97656A
Authority
IL
Israel
Prior art keywords
dione
dihydro
dipropyl
compound according
purine
Prior art date
Application number
IL9765691A
Other languages
English (en)
Hebrew (he)
Other versions
IL97656A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL97656A0 publication Critical patent/IL97656A0/xx
Publication of IL97656A publication Critical patent/IL97656A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL9765691A 1990-03-26 1991-03-22 History of 1,3-dipropyl-8-aralkyl xanthine, the process for their preparation and medicinal preparations containing them IL97656A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/499,111 US5047534A (en) 1990-03-26 1990-03-26 Selective adenosine receptor agents

Publications (2)

Publication Number Publication Date
IL97656A0 IL97656A0 (en) 1992-06-21
IL97656A true IL97656A (en) 1996-06-18

Family

ID=23983864

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9765691A IL97656A (en) 1990-03-26 1991-03-22 History of 1,3-dipropyl-8-aralkyl xanthine, the process for their preparation and medicinal preparations containing them

Country Status (22)

Country Link
US (1) US5047534A (no)
EP (1) EP0449175B1 (no)
JP (1) JP3181305B2 (no)
KR (1) KR100195368B1 (no)
CN (1) CN1032815C (no)
AR (1) AR247887A1 (no)
AT (1) ATE156130T1 (no)
AU (1) AU632914B2 (no)
CA (1) CA2038747C (no)
DE (1) DE69127010T2 (no)
DK (1) DK0449175T3 (no)
ES (1) ES2107431T3 (no)
FI (1) FI98461C (no)
GR (1) GR3025135T3 (no)
HU (1) HU208824B (no)
IE (1) IE910982A1 (no)
IL (1) IL97656A (no)
NO (1) NO177591C (no)
NZ (1) NZ237484A (no)
PH (1) PH27511A (no)
PT (1) PT97133B (no)
ZA (1) ZA912038B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
CA2116967C (en) * 1992-07-08 2003-08-19 Fumio Suzuki Antidepressants
ES2120025T3 (es) * 1993-02-26 1998-10-16 Merrell Pharma Inc Derivados de xantina utilizados como antagonistas de receptores de adenosina a1.
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
WO1994026744A1 (en) * 1993-05-06 1994-11-24 Merrell Dow Pharmaceuticals Inc. 8-substituted xanthines as selective adenosine receptor agents
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
ATE481101T1 (de) * 2003-06-10 2010-10-15 Kyowa Hakko Kirin Co Ltd Verfahren zur behandlung von angstzuständen
WO2007036491A1 (de) * 2005-09-30 2007-04-05 Basf Aktiengesellschaft Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR102060903B1 (ko) * 2018-09-12 2019-12-30 김지훈 다중접합 도마 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung

Also Published As

Publication number Publication date
CA2038747A1 (en) 1991-09-27
IL97656A0 (en) 1992-06-21
KR100195368B1 (ko) 1999-06-15
ES2107431T3 (es) 1997-12-01
PT97133A (pt) 1991-12-31
NO911200L (no) 1991-09-27
CN1055181A (zh) 1991-10-09
FI911420A0 (fi) 1991-03-25
NO177591B (no) 1995-07-10
PH27511A (en) 1993-08-18
CN1032815C (zh) 1996-09-18
AU7353791A (en) 1991-10-03
AR247887A1 (es) 1995-04-28
PT97133B (pt) 1998-07-31
HU208824B (en) 1994-01-28
IE910982A1 (en) 1991-10-09
HUT56570A (en) 1991-09-30
EP0449175B1 (en) 1997-07-30
GR3025135T3 (en) 1998-02-27
EP0449175A2 (en) 1991-10-02
ATE156130T1 (de) 1997-08-15
JP3181305B2 (ja) 2001-07-03
NO177591C (no) 1995-10-18
AU632914B2 (en) 1993-01-14
FI98461B (fi) 1997-03-14
EP0449175A3 (en) 1993-01-20
NO911200D0 (no) 1991-03-25
DE69127010D1 (de) 1997-09-04
DK0449175T3 (da) 1998-02-23
JPH04221384A (ja) 1992-08-11
CA2038747C (en) 2002-05-28
FI98461C (fi) 1997-06-25
DE69127010T2 (de) 1997-11-13
US5047534A (en) 1991-09-10
FI911420A (fi) 1991-09-27
ZA912038B (en) 1991-12-24
NZ237484A (en) 1993-10-26
KR910016752A (ko) 1991-11-05

Similar Documents

Publication Publication Date Title
CA2024381C (en) Xanthine compounds
EP0203721A2 (en) 8-Phenyl xanthines
CA2344828A1 (en) ¬1,2,4|triazolo¬1,5-c|pyrimidine derivatives
US5047534A (en) Selective adenosine receptor agents
CA2155130C (en) Xanthine derivatives as adenosine a1 receptor antagonists
JP2954971B2 (ja) 選択的アデノシン受容体剤
US5734052A (en) 8-substituted xanthines as selective adenosine receptor agents
US5064947A (en) Selective adenosine reseptor compounds
EP0662975B1 (en) 2-substituted adenosines with a-2 receptor affinity
EP0390111B1 (en) Selective adenosine receptor compounds
US5426101A (en) 2-substituted adenosines with A-2 receptor affinity
US5086176A (en) Tricyclic fused adenine derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees